Brain Education and Wellness Program for Migraine
Trial Summary
Will I have to stop taking my current medications?
No, you can stay on all your current medications during this study. However, you need to maintain stable dosages throughout the study.
What data supports the effectiveness of the Brain Education and Wellness Program for Migraine treatment?
Is the Brain Education and Wellness Program for Migraine safe for humans?
How does the Brain Education and Wellness Program for Migraine differ from other migraine treatments?
The Brain Education and Wellness Program for Migraine, which includes Mindfulness-Based Stress Reduction (MBSR), is unique because it is a non-drug treatment that focuses on meditation and stress reduction, offering an inexpensive option without side effects. Unlike medications, it addresses both pain and psychological well-being, improving sleep quality and potentially reducing headache frequency.12367
What is the purpose of this trial?
The goal of this randomized clinical trial is to evaluate two different non-drug, virtual treatment options designed to improve the lives of patients with migraine. Both interventions involve 8 weekly sessions and an online platform with additional content and learning. Participants can stay on all their medications during this study. Information from this study may help determine how to better treat migraine.
Research Team
Rebecca E Wells, MD, MPH
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for adults with migraines occurring 4-20 days a month, who've had migraines for at least a year. Participants must be fluent in English, able to attend 8 weekly online classes, and willing to keep headache logs. Pregnant women up to 16 weeks can join. Those with heavy alcohol/drug use, other clinical trial participation, meditation experience or unstable medical conditions are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in 8 weekly virtual sessions plus use of an online platform
Follow-up
Participants are monitored for changes in migraine-related outcomes post-intervention
Long-term Follow-up
Participants' migraine disability is assessed at 20 and 32 weeks post-intervention
Treatment Details
Interventions
- Brain Education and WELLness with Migraine Group A
- Brain Education and WELLness with Migraine Group B
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator